Coloplast delivered fiscal second-quarter results that featured progress toward normalized, prepandemic dynamics in the U.S. However, the omicron variant and ongoing lockdowns in China have put slight ...
In addition to significant foreign exchange headwinds in fiscal second quarter, Coloplast also faced anemic demand thanks to the pandemic--an atypical situation for this firm. However, we anticipate ...
Coloplast has signed an agreement to acquire Atos Medical, the global market leader in laryngectomy from PAI Partners, a global private equity firm headquartered in Paris. Atos Medical’s purpose of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback